Project Grant R21AG096566
Award Date 9/15/25
Completion Date 9/14/27
Dollars Obligated $422K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Michigan, USA
Similar Awards
- This federal Project Grant award of $2,709,669 from the National Institute on Aging (Aging Research, CFDA 93.866) aims to provide rigorous evidence on the outcomes of home-based versus facility-based care for older patients with Alzheimer's disease and related dementias (AD/ADRD). The research strategy will leverage differences in the influence of physical therapists on discharge destination as a "randomizing device" to compare outcomes across almost 100 VA hospitals. This novel...
- This Project Grant award from the National Institutes of Health (NIH) National Institute on Aging (CFDA 93.866 - Aging Research) will support research to investigate the role of transposable elements (TEs) in Alzheimer's disease (AD) and related dementias (ADRD). The $303,449 award to the Regents of the University of Michigan will leverage large genomic and clinical datasets to analyze the prevalence and functional impact of TEs on AD and ADRD phenotypes. The project aims to develop a predictive...
- The National Institute on Aging (NIA) awarded a $1,987,023 Project Grant under the Aging Research program (CFDA 93.866) to the Regents of the University of Michigan to develop new measurement tools and computer adaptive tests to better characterize the experiences of non-traditional and minority informal caregivers of individuals living with Alzheimer's disease and related dementias. The 3-year project aims to identify critical elements of the caregiving role through semi-structured interviews...
- This $322,286 federal Project Grant award from the National Institute on Aging's Aging Research program (CFDA 93.866) supports research to advance health equity in the use of novel treatments for Alzheimer's disease and related dementias (ADRD). The primary objectives are to: Conduct focus groups with diverse individuals affected by ADRD to understand their medication decision-making processes. Design and administer discrete choice experiments to learn how different treatment attributes are...
- This Project Grant award of $794,956 from the National Institute on Aging (NIA) Aging Research program (CFDA 93.866) aims to evaluate the effectiveness of Transitional Care Management (TCM) and Chronic Care Management (CCM) services in improving health outcomes and reducing healthcare costs for older adult Medicare beneficiaries. The research will employ a target trial emulation approach to compare TCM and CCM services to usual care, with a focus on outcomes such as home time, survival, and...
- This $562,314 federal Project Grant awarded by the National Institute on Aging under the Aging Research program (CFDA 93.866) supports a 3-year study to identify risk and protective factors associated with psychosocial resilience in spousal caregivers for spouses with Alzheimer's disease and related dementias. The study leverages data from several large, longitudinal cohort studies, including the Health and Retirement Study, to examine how caregivers' well-being, mental health, and cognitive...
- This $2,528,708 federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) supports research on the impact of undiagnosed Alzheimer's disease and related dementias (AD/ADRD) on healthcare utilization across geographic regions in the United States. The project will leverage Medicare claims data and cognitive assessment data from the REGARDS longitudinal cohort study to model the timeframe and consequences of undiagnosed AD/ADRD at the county and hospital...
- This federal Project Grant award of $331,439 from the National Institute on Aging (CFDA 93.866 - Aging Research) supports a research project titled "Health Equity in Alzheimer's Treatment (HEAT)". The key objectives of the project are to: Use qualitative and quantitative methods to better understand the preferences, diagnostic/monitoring burden, and cost factors affecting the real-world effectiveness of new anti-amyloid Alzheimer's medications in predominantly Black and low-income...
- This federal Project Grant award of $204,806 from the National Institute on Aging (CFDA 93.866 Aging Research) aims to adapt an evidence-based creative storytelling intervention called TimeSlips for older adults with mild cognitive impairment or mild Alzheimer's disease and related dementias in the primary care setting. The award will fund a pilot randomized trial of the adapted intervention, called TIME2CONNECT, to assess its potential to reduce loneliness in this population. The grant...
- The National Institute on Aging (NIA), part of the U.S. Department of Health and Human Services, awarded a $320,000 Project Grant under the Aging Research federal grant program (CFDA 93.866) to Northwestern University. The purpose of this 2-year grant, with a start date of September 1, 2025, is to conduct a study to understand participant perspectives on respite care (adult day services) uptake among caregivers of adults with Alzheimer's disease and related dementias. The study aims to explore...